IRW improves diet-induced non-alcoholic fatty liver disease by reducing steatosis associated with increased capacity for oxidative phosphorylation

IRW improves diet-induced non-alcoholic fatty liver disease by reducing steatosis associated with increased capacity for oxidative phosphorylation

Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, remains without approved pharmacological treatment. Food-derived bioactive peptides can aid in the management of metabolic conditions including hypertension, obesity and insulin resistance. IRW (isoleucin...

Full description

Bibliographic Details
Main Authors: Stepheny C. de Campos Zani, Emily Berg, Xu Jiang, Alexandra Knox, Evan Ackroyd, Aaron Getachew, Jianping Wu, Catherine B. Chan
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Journal of Functional Foods
Subjects:
Bioactive peptides
NAFLD
Obesity
Liver
IRW
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464623005765

Internet

http://www.sciencedirect.com/science/article/pii/S1756464623005765

Similar Items